ImmuMap CEO to present at ENVIGO Immuno-oncology symposium

CEO of ImmuMap Thomas M. Frøsig has been invited to present our view on in vitro mechanism-of-action analyses at the Biologics Symposium for Immuno-Oncology products organized by the very large contract-research organization (CRO) ENVIGO. We look forward to participate in an exciting symposium!

The symposium will be held twice, Tuesday 16 January in Copenhagen and Thursday 18 January in Stockholm.

Get in touch with us at ImmuMap

– Do you have questions about our work?

ImmuMap - DTU Science Park, Diplomvej 377, 2800 Kgs. Lyngby, Denmark - Tel: +45 6178 1882

Call Now